Gales Ferry, CT, United States of America

Timothy Norris



Average Co-Inventor Count = 2.8

ph-index = 5

Forward Citations = 159(Granted Patents)


Location History:

  • New York, NY (US) (1998)
  • Gales Ferry, CT (US) (1999 - 2009)

Company Filing History:


Years Active: 1998-2009

Loading Chart...
Loading Chart...
19 patents (USPTO):Explore Patents

Title: Innovations in Cancer Treatment: The Patents of Timothy Norris

Introduction: Timothy Norris, a prominent inventor located in Gales Ferry, CT, has made significant contributions to the field of pharmaceuticals, particularly in cancer treatment. With a portfolio of 19 patents, Norris has developed groundbreaking compounds aimed at combating hyperproliferative disorders.

Latest Patents: Norris's latest inventions include two notable patents focusing on N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine mesylate. The first patent describes both the anhydrous and hydrate forms of this compound, emphasizing its pharmaceutical compositions and methods for treating disorders like cancer. The second patent outlines a method of monotherapy using a stable polymorph of N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride, specifically targeting abnormal cell growth that expresses the epidermal growth factor receptor (EGFR).

Career Highlights: Throughout his career, Timothy Norris has made impactful strides in pharmaceutical research while working for reputable organizations such as Pfizer Corporation and Osi Pharmaceuticals, Inc. His expertise in drug development has played a pivotal role in advancing therapeutic options for patients.

Collaborations: Norris has collaborated with several esteemed professionals in his field, including John F. Lambert and Jeffrey W. Raggon. These partnerships have fostered innovation and played a crucial role in the successful development of his patented inventions.

Conclusion: Timothy Norris's dedication to the advancement of medical science through his patents exemplifies the importance of innovation in the pharmaceutical industry. His contributions not only reflect his commitment to improving cancer treatment but also underscore the collaborative nature of scientific discovery that drives progress in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…